View Study [4]"Inhibition of activin-like kinase 4/5 attenuates cancer cachexia associated muscle wasting" Levolger S, Wiemer EAC, et al., 2019 Finding: LR3 IGF-I treatment effectively limited muscle mass loss in a cancer cachexia model, demonstrating its potent anti-catabolic effects and ability to preserve muscle tissue under conditions that normally cause severe muscle wasting
The result can include increased oxidative stress, inflammation, and cellular damage
Alexei Savchenko and Nobuhiko Watanabe at the University of Calgary
NEWS EXPLAINER Are obesity drugs causing a severe complication
Key technologies that reduce medication errors include the following 18,20,21 : Barcode scanning as an additional verification step in the dispensing and administration process ensures that the correct drug, dose, and patient matches the prescription and manufacturer specifications
As more consumers adjust their eating habits due to the appetite-suppressing effects of GLP-1 medications, food manufacturers are rethinking portion sizes, nutritional profiles, and product formulation strategies
